首页> 外国专利> CELLULAR SUSPENSION FOR USE IN THE TREATMENT OF DISEASES OF PERIPHERAL ARTERIES OF THE LOWER EXTREMITIES

CELLULAR SUSPENSION FOR USE IN THE TREATMENT OF DISEASES OF PERIPHERAL ARTERIES OF THE LOWER EXTREMITIES

机译:细胞悬液用于治疗下肢周围动脉疾病

摘要

The present invention relates to a cell suspension of autologous or allogeneic, preferably autologous, mature white blood cells of bone marrow origin, preferably originating from the iliac crest (or iliac crest), enriched in mononuclear cells, which means more than 25% of the white blood cells (WBC) present in a cell suspension, are mononuclear cells that contains A) mononuclear cells (MNC) selected from a list containing or consisting of: i) a lim population otsitov; ii) populations of monocytes; and iii) populations of hematopoietic stem cells expressing CD34; and where the cell suspension further comprises B) granulocytes; for use in treating or improving peripheral arterial disease of the lower extremities.
机译:本发明涉及骨髓来源的自体或同种异体的,优选自体的,成熟的白细胞的细胞悬浮液,优选来源于the(或),其富含单核细胞,这意味着超过25%的白细胞。存在于细胞悬液中的白细胞(WBC)是包含A)单核细胞(MNC)的单核细胞,该单核细胞选自包含以下各项或由以下各项组成的列表: ii)单核细胞的种群; iii)表达CD34的造血干细胞群体;并且其中细胞悬浮液还包含B)粒细胞;用于治疗或改善下肢的外​​周动脉疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号